Fuda Cancer Hospital
Stomach cancer treatment cost in China runs from Price on request to Price on request for a gastroscopy. Major procedures like stomach cancer surgery costs $18,500 to $34,500, while chemotherapy for stomach cancer ranges from Price on request to Price on request . Total expenses depend on the cancer stage, hospital tier, and surgical approach. International patients typically see 80-85% savings compared to the US. Top cities for oncology include Guangzhou, Shanghai, and Beijing.
Typical Stomach Cancer Treatment Costs in China
Bookimed Expert Insight: Advanced-stage patients often benefit from integrated, non-traditional protocols. Fuda Cancer Hospital specializes in late-stage care using NanoKnife and cryosurgery. This JCI-accredited facility has served 30,000 international patients. For those needing precision radiation, Dr. Liu Shi Xin at Xiamen Humanity Hospital offers expert-led radiotherapy. Choosing specialized oncology hubs provides better value for complex, multidisciplinary cases than general hospitals.
| China | Turkey | Austria | |
| Stomach resection | from $18,500 | from $12,000 | from $22,000 |
| Stomach cancer surgery | from $18,500 | from $8,500 | from $30,000 |
| Radiation therapy for stomach cancer | from $8,500 | from $3,250 | from $6,954 |
| Proton-beam therapy | from $36,500 | from $70,000 | from $80,000 |
| NanoKnife | from $22,500 | from $9,500 | from $25,000 |
Dr. Liu Shi Xin is the Vice Chairman of the Radiation Oncology Branch of the Chinese Medical Association. He serves as the Discipline Leader of the Oncology Center at Xiamen Humanity Hospital. Dr. Liu specializes in precision radiotherapy for thoracic and abdominal cancers. He is a recipient of the State Council Special Government Allowance for his medical contributions.
Professor Zheng Qiu Hong is Director of the Cell Therapy Research Center and a National Senior Expert in Biotherapy. He is a Professor and Master’s Supervisor at Fujian Medical University. He has more than 30 years of clinical experience in tumor molecular biology and biotherapy. From 2012 to 2013, he was a visiting scholar in stem cell research at the University of Connecticut School of Life Sciences. He previously held leadership roles at Fujian Cancer Hospital. These roles included Director of the Tumor Molecular Biology Laboratory and Director of the Surgical Oncology Research Laboratory. He also served as Deputy Director of the Fujian Key Laboratory of Tumor Biotherapy and Deputy Director of the Biotherapy and Immunotherapy Center.
Appointments include Standing Committee Member of the Biotherapy Committee of the Chinese Research Hospital Association. He is also a Committee Member of the Tumor Immunology and Biotherapy Committee of the Chinese Society for Immunology. In addition, he is Deputy Chair of the Academic Committee of the Xiamen Cell Therapy Research Center at the First Affiliated Hospital of Xiamen University.
Professor Liang Xiaoxiao is the Department Director and Chief Physician in Neurorehabilitation. She holds a master’s degree in neurology. She is skilled in neuromodulation for disorders of consciousness, cognition, and movement. Her focus includes cases from cerebrovascular disease, Parkinson’s disease, and related conditions. She also performs ultrasound-guided botulinum toxin injections for blepharospasm, hemifacial spasm, limb spasticity, sialorrhea, and neuralgia.
Accreditations and roles: Member of the Neurorehabilitation, Cognitive Disorder Rehabilitation, and Craniocerebral Trauma Rehabilitation Committees of the Chinese Association of Rehabilitation Medicine. Standing Member of the Cognitive Disorder Rehabilitation Committee of the Fujian Association of Rehabilitation Medicine. Vice Chair of the Dementia and Cognitive Disorder Committee of the Xiamen Preventive Medicine Association. Vice President of the Parkinson’s Disease and Movement Disorders Committee of the Xiamen Medical Doctor Association. Standing Member of the Neuromodulation Committee of the Xiamen Medical Doctor Association. Recipient of the Most Beautiful Physician of Xiamen City (2024).
Dr. Leng Yin specializes in treating cancers of the liver, gallbladder, stomach, pancreas, and intestines at Fuda Cancer Hospital.
Chinese oncologists at top-tier facilities follow national certification standards that align with international benchmarks. Leading surgeons often hold Chief Physician titles and practice in JCI-accredited hospitals. These specialists frequently maintain memberships in global bodies like the Chinese Anti-Cancer Association while following internationally recognized CSCO treatment guidelines.
Bookimed Expert Insight: Case volume in China often translates to higher technical proficiency for stomach cancer. Specialists at flagship hospitals may perform 1,000+ gastrectomies annually. This volume far exceeds most Western counterparts. When selecting a surgeon, prioritize those at JCI-accredited facilities in Guangzhou or Shanghai. These doctors frequently hold dual training from Western or Japanese institutions, ensuring they meet rigorous international surgical protocols.
Patient Consensus: Patients emphasize choosing surgeons at Tier-1 hospitals in major cities for the best results. They note that top doctors often speak English well and have extensive experience with robotic or laparoscopic techniques.
The 5-year survival rate for stomach cancer in China ranges from 35.1% to 46.1% nationwide. Specialized cancer centers report surgical survival rates reaching 69.8%. Early-stage diagnosis (Stage I) offers the best prognosis. Survival for these patients often reaches 85% to 95%.
Bookimed Expert Insight: Clinical data shows a major distinction between general hospitals and high-volume specialty centers in Guangzhou. Fuda Cancer Hospital has treated over 30,000 international patients. It focuses on minimally invasive therapies like NanoKnife. Choosing centers that prioritize these technologies over standard chemotherapy often improves quality of life during treatment.
Patient Consensus: Patients emphasize that frequent screening in China helps catch cancer earlier than in Western countries. Many survivors stress the importance of verifying that a surgeon performs at least 20 gastrectomies annually for the best outcomes.
Laparoscopic and robotic gastrectomy are widely available in China for treating stomach cancer. These minimally invasive techniques are safe alternatives to open surgery. Both approaches offer faster recovery times. Surgeons use the Da Vinci Robotic System for high precision and 3D visualization.
Bookimed Expert Insight: While robotic surgery takes longer to set up, it is the superior choice for patients with complex cases or high BMI. Fuda Cancer Hospital in Guangzhou treats over 30,000 international patients and maintains JCI-accredited safety standards. Their specialists, like Dr. Leng Yin, often prioritize these minimally invasive methods to reduce trauma in advanced cases.
Patient Consensus: Patients find that the smaller incisions lead to much less pain after surgery. They often feel more comfortable and mobile just a few days after the procedure.
Stomach cancer treatment in China typically requires between 4 weeks and 6 months depending on the stage. Early-stage endoscopic procedures take only 1 to 2 days. Complex surgical pathways usually involve 2 weeks of hospitalization followed by 4 weeks of local recovery before flying.
Bookimed Expert Insight: Patients should note that Chinese clinical protocols, like those at Fuda Cancer Hospital, often favor longer inpatient stays than Western facilities. While a gastrectomy might have a 5-day hospital stay in the US, Chinese specialists often require 14 to 21 days. This approach focuses on intensive monitoring for post-operative leaks and immediate nutritional stabilization before discharge to a hotel.
Patient Consensus: Patients emphasize building in a 2-week buffer for discharge delays or minor recovery hurdles like delayed gastric emptying. Many recommend arranging follow-up chemotherapy with a local oncologist at home to avoid staying in-country for several months.
Guangzhou, Beijing, and Shanghai are the primary Chinese hubs for international patients seeking experienced stomach cancer care. These cities host JCI-accredited facilities specializing in advanced therapies. Specialized centers utilize cryosurgery, NanoKnife, and robotic-assisted resections for complex and late-stage gastric oncology cases.
Bookimed Expert Insight: While Beijing and Shanghai are prestigious, Guangzhou offers a unique balance of high volume and lower costs. Our data indicates that Sun Yat-sen University Cancer Center provides treatments approximately 30% to 50% more affordably than Beijing facilities. Furthermore, clinics like Fuda Cancer Hospital offer specialized interventions such as cryosurgery for late-stage cases. These are often unavailable at standard international hubs.
Patient Consensus: Patients note that public hospitals with dedicated international departments provide the best surgical volume. Many recommend hiring private translators in Shanghai and Beijing to navigate the complex hospital systems efficiently.
Post-operative dietary support for stomach cancer in China follows structured Enhanced Recovery After Surgery (ERAS) protocols. International patients receive personalized plans. These plans transition from full liquids to regular meals over 6 months. Multidisciplinary teams, including clinical dietitians, monitor nutritional intake and hydration status to ensure safe recovery.
Bookimed Expert Insight: JCI-accredited clinics like Fuda Cancer Hospital demonstrate a commitment to international safety standards. With over 30,000 international patients treated, these centers adapt traditional Chinese recovery foods. For example, dietitians may remove MSG from menus to better suit Western tastes. They also provide printed English guides to manage recovery after discharge.
Patient Consensus: Patients note that rice porridge and protein shakes are recovery staples. Many recommend using translation apps for dietitian visits and bringing electrolyte packets for easier hydration during the liquid phase.
Most international patients require a medical visa for stomach cancer treatment in China. JCI-accredited facilities provide essential invitation letters required for S1, S2, or M visas. Citizens from over 50 countries may currently benefit from 30-day visa-free entry for medical purposes.
Bookimed Expert Insight: Fuda Cancer Hospital serves over 30,000 international patients and manages complex visa paperwork efficiently. Our data shows hospitals in Guangzhou often email invitation letters within 48 hours. This speed is vital for patients seeking time-sensitive therapies like NanoKnife or Cryosurgery. Choosing a hospital experienced in international logistics ensures your entry permit matches the required treatment duration.
Patient Consensus: Patients note that emailing a preliminary diagnosis and passport scan quickly secures the invitation letter. Many suggest traveling with a companion as hospitals often bundle family visa invitations together.